Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismMYD88 modulators |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with SPIMA Therapeutics
0 Patents (Medical) associated with SPIMA Therapeutics
100 Deals associated with SPIMA Therapeutics
100 Translational Medicine associated with SPIMA Therapeutics